Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis
NCT00082173Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Oct 2004
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of moxifloxacin in pulmonary tuberculosis (TB), sponsored by Johns Hopkins University. Started Oct 2004; status: completed.
02
Drugs
moxifloxacin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00082173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082173.